作者
Miles Berger, Mary Cooter, Alexander S Roesler, Stacey Chung, John Park, Jennifer L Modliszewski, Keith W VanDusen, J Will Thompson, Arthur Moseley, Michael J Devinney, Shayan Smani, Ashley Hall, Victor Cai, Jeffrey N Browndyke, Michael W Lutz, David L Corcoran, Alzheimer’s Disease Neuroimaging Initiative
发表日期
2021/1/1
期刊
Journal of Alzheimer's Disease
卷号
79
期号
2
页码范围
511-530
出版商
IOS Press
简介
Background
APOE4 has been hypothesized to increase Alzheimer’s disease risk by increasing neuroinflammation, though the specific neuroinflammatory pathways involved are unclear.
Objective
Characterize cerebrospinal fluid (CSF) proteomic changes related to APOE4 copy number.
Methods
We analyzed targeted proteomic data from ADNI CSF samples using a linear regression model adjusting for age, sex, and APOE4 copy number, and additional linear models also adjusting for AD clinical status or for CSF A, tau, or p-tau levels. False discovery rate was used to correct for multiple comparisons correction.
Results
Increasing APOE4 copy number was associated with a significant decrease in a CRP peptide level across all five models (q< 0.05 for each), and with significant increases in ALDOA, CH3L1 (YKL-40), and FABPH peptide levels (q< 0.05 for each) except when controlling for AD clinical status or …
引用总数
20212022202320242643
学术搜索中的文章
M Berger, M Cooter, AS Roesler, S Chung, J Park… - Journal of Alzheimer's Disease, 2021